Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
US8575217B2 · kind B2 · utility
6Cited by
42References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 2010 |
| Grant date | Nov 5, 2013 |
| Priority date | — |
| Expiry date | Jan 15, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to methods for treating metabolic disorders with compounds that are conjugates. The conjugates of the present invention are comprised of salicylic acid, triflusal, diflusinal, salsalate, IMD-0354, ibuprofen, diclofenac, licofelone, or HTB, and one or more antioxidants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.